This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991:5 Suppl 2:S21-33.

doi: 10.1097/00002030-199101001-00004.

The role of the V3 loop of gp120 in HIV infection

J P Moore¹, P L Nara

Affiliations

PMID: 1845049
DOI: 10.1097/00002030-199101001-00004

Review

The role of the V3 loop of gp120 in HIV infection

J P Moore et al. AIDS. 1991.

. 1991:5 Suppl 2:S21-33.

doi: 10.1097/00002030-199101001-00004.

Authors

J P Moore¹, P L Nara

Affiliation

¹ Chester Beatty Laboratories, Institute of Cancer Research, London, UK.

PMID: 1845049
DOI: 10.1097/00002030-199101001-00004

No abstract available

PubMed Disclaimer

Similar articles

Assimilating HIV sequences.
Myers G. Myers G. AIDS Res Hum Retroviruses. 1993 Jul;9(7):697-702. doi: 10.1089/aid.1993.9.697. AIDS Res Hum Retroviruses. 1993. PMID: 8369174 No abstract available.
Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus.
Albert J, Franzén L, Jansson M, Scarlatti G, Kataaha PK, Katabira E, Mubiro F, Rydåker M, Rossi P, Pettersson U, et al. Albert J, et al. Virology. 1992 Oct;190(2):674-81. doi: 10.1016/0042-6822(92)90905-5. Virology. 1992. PMID: 1519357
Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
Vu HM, de Lorimier R, Moody MA, Haynes BF, Spicer LD. Vu HM, et al. Biochemistry. 1996 Apr 23;35(16):5158-65. doi: 10.1021/bi952665x. Biochemistry. 1996. PMID: 8611499
NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity.
Sharon M, Rosen O, Anglister J. Sharon M, et al. Curr Opin Drug Discov Devel. 2005 Sep;8(5):601-12. Curr Opin Drug Discov Devel. 2005. PMID: 16159022 Review.
Structural studies of human HIV-1 V3 antibodies.
Stanfield RL, Wilson IA. Stanfield RL, et al. Hum Antibodies. 2005;14(3-4):73-80. Hum Antibodies. 2005. PMID: 16720977 Review.

See all similar articles

Cited by

Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
Willey RL, Theodore TS, Martin MA. Willey RL, et al. J Virol. 1994 Jul;68(7):4409-19. doi: 10.1128/JVI.68.7.4409-4419.1994. J Virol. 1994. PMID: 7515973 Free PMC article.
Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses.
Freel SA, Williams JM, Nelson JA, Patton LL, Fiscus SA, Swanstrom R, Shugars DC. Freel SA, et al. J Virol. 2001 May;75(10):4936-40. doi: 10.1128/JVI.75.10.4936-4940.2001. J Virol. 2001. PMID: 11312368 Free PMC article.
Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response.
Laird ME, Igarashi T, Martin MA, Desrosiers RC. Laird ME, et al. J Virol. 2008 Nov;82(22):11054-65. doi: 10.1128/JVI.01341-08. Epub 2008 Sep 3. J Virol. 2008. PMID: 18768967 Free PMC article.
Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.
Kayman SC, Wu Z, Revesz K, Chen H, Kopelman R, Pinter A. Kayman SC, et al. J Virol. 1994 Jan;68(1):400-10. doi: 10.1128/JVI.68.1.400-410.1994. J Virol. 1994. PMID: 7504740 Free PMC article.
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Roben P, et al. J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information